ctrl K

Silverback Therapeutics I... (SBTX)

NASDAQ: SBTX · Real-Time Price · USD

5.87

0.06 (1.03%)

At close: Nov 09, 2022, 5:00 AM

Silverback Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Cash & Equivalents	210.52M	254.04M	386.57M	9.98M	20.16M
Short-Term Investments	63.86M	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	64.78M	n/a	n/a	n/a
Other Long-Term Assets	2.96M	250K	350K	550K	750K
Receivables	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a
Other Current Assets	3.32M	7.45M	4.09M	552K	618K
Total Current Assets	277.7M	261.49M	390.66M	10.53M	20.78M
Property-Plant & Equipment	774K	6.95M	3.8M	4.57M	6.02M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	3.73M	71.97M	4.15M	5.12M	6.77M
Total Assets	281.44M	333.47M	394.8M	15.65M	27.55M
Account Payables	n/a	2.08M	2.58M	3.52M	775K
Deferred Revenue	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	230K	1.09M	844K	11.51M	2.85M
Other Current Liabilities	5.21M	11.73M	6.17M	2.9M	1.52M
Total Current Liabilities	5.44M	14.89M	9.6M	17.93M	5.14M
Long-Term Debt	251K	4.76M	2.33M	n/a	n/a
Other Long-Term Liabilities	2.85M	n/a	n/a	56.5M	57.38M
Total Long-Term Liabilities	3.1M	4.76M	2.33M	56.5M	57.38M
Total Liabilities	8.55M	19.65M	11.93M	74.42M	62.52M
Total Debt	481K	5.85M	4.07M	15.62M	7.73M
Common Stock	9K	4K	3K	n/a	n/a
Retained Earnings	-76.94M	-186.21M	-96.73M	-63.79M	-39.82M
Comprehensive Income	n/a	-326K	-2.05M	-1.45M	-906K
Shareholders Equity	272.89M	313.81M	382.88M	-58.78M	-34.98M
Total Investments	63.86M	64.78M	n/a	n/a	n/a